Interestingly, in anearly study with an mTOR inhibitor (deGraffenriedet al. 2004) rapamycin ester (CCI-779) treatment restoredtamoxifen response in tamoxifen-resistant breast carcinoma (Yu et al. 2001). This evidence concerns the gene MTOR and breast carcinoma.